Company: INVUP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001493152-25-011912
Chunk: 24

Company: Investview, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 24
---
 table illustrates the computation of diluted earnings per share for the three months ended June 30, 2025 and 2024.

SCHEDULE OF DILUTED EARNINGS PER SHARE 

    June 30, 2025  
    June 30, 2024 
  
    Net income 
    $428,278  
     532,847 
  
    Less: net income attributable to noncontrolling interest 
     (2,781) 
     - 
  
    Less: preferred dividends 
     (204,835) 
     (204,835)
  
    Add: interest expense on convertible debt 
     225,129  
     225,129 
  
    Net income available to common shareholders (numerator) 
    $445,791  
     553,141 

    Basic weighted average number of common shares outstanding 
     1,858,586,010  
     1,860,981,786 
  
    Dilutive impact of convertible notes 
     471,428,571  
     471,428,571 
  
    Dilutive impact of non-voting membership interest 
     565,000,000  
     565,000,000 
  
    Diluted weighted average number of common shares outstanding (denominator) 
     2,895,014,581  
     2,897,410,357 

    Diluted income per common share 
    $0.00  
     0.00 

The
following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as
their inclusion would be anti-dilutive.

SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES 

    June 30, 2025  
    June 30, 2024 
  
    Weighted average options to purchase common stock 
     351,416,665  
     361,416,665 
  
    Weighted average warrants to purchase common stock 
     1,158,997  
     1,178,090 

Due
to the net loss for the six months ended June 30, 2025, basic and diluted income per share were the same, as all securities had an anti-dilutive
effect.

The
following table illustrates the computation of diluted earnings per share for the six months ended June 30, 2024.